Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in Childhood
Helicobacter · 2025-07 · 30 (4)
DOI: 10.1111/hel.70063 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Helicobacter, online erschienen am 12.08.2025. Verfasst von Matjaž Homan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, and Nutrition, University Children's Hospital, Faculty of Medicine, University of Ljubljana, Ljubljana, S…. Hauptthemen laut MEDLINE: Helicobacter Infections, Anti-Bacterial Agents, Helicobacter pylori. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Helicobacter pylori infection in children and adults differs in several aspects such as the natural history, prevalence, the clinical presentations and complications, antibiotic resistance rates, treatment options, and the success rates of treatment. Due to all the abovementioned differences, management guidelines and recommendations are different between children and adults. In parallel to the steady decrease in the rate of H. pylori infection in the Western world in recent years, both in children and adults, antibiotic resistance rates have risen to alarming rates. The risk and benefits of eradication treatment, especially in children, must be considered when deciding “to treat or not.” The risks include the negative effects of antibiotics, treatment failure, and reinfection as well as the possibility of losing the “protective effect” of H. pylori on atopy, allergy, and possibly on other gastrointestinal diseases. On the other hand, there are also many benefits of eradication therapy such as prevention of gastric complication and associated non‐gastric complications as well as reduction of parental anxiety of nontreatment. This review summarizes the differences related to H. pylori in children versus adults and the risks and benefits of treatment in children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology, and Nutrition, University Children's Hospital, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
- INSERM U1312 BRIC, University of Bordeaux, Bordeaux, France.
- Pediatric Gastroenterology, Kaplan Medical Center, Faculty of Medicine, Hebrew University Jerusalem, Israel.
ORCID-Profile: Matjaž Homan, Francis Megraud
Zitieren
APA
Homan, M., Mišak, Z., Megraud, F., & Kori, M. (2025). Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in Childhood. Helicobacter, 30(4). https://doi.org/10.1111/hel.70063
Vancouver
Homan M, Mišak Z, Megraud F, Kori M. Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in Childhood. Helicobacter. 2025;30(4). doi:10.1111/hel.70063
BibTeX
@article{Homan2025,
author = {Homan, Matjaž and Mišak, Zrinjka and Megraud, Francis and Kori, Michal},
title = {Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in Childhood},
journal = {Helicobacter},
year = {2025},
volume = {30},
number = {4},
doi = {10.1111/hel.70063}
}
EUVIMED